CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2015 on Monday, November 9, 2015, before the U.S. financial markets open.
Management will provide an update on the company, discuss third quarter 2015 results, and discuss expectations for the future via conference call on Monday, November 9, 2015 at 8:00 a.m. ET. To access the call, please dial 877-312-7507 (domestic) or 631-813-4828 (international) five minutes prior to the start time and refer to conference ID 68373075.
Help employers find you! Check out all the jobs and post your resume.
Management will provide an update on the company, discuss third quarter 2015 results, and discuss expectations for the future via conference call on Monday, November 9, 2015 at 8:00 a.m. ET. To access the call, please dial 877-312-7507 (domestic) or 631-813-4828 (international) five minutes prior to the start time and refer to conference ID 68373075.
Help employers find you! Check out all the jobs and post your resume.
